Cost‐Utility Analysis of Pembrolizumab Versus...

Cost‐Utility Analysis of Pembrolizumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer With Different PD-L1 Expression Levels

Weng, Xiuhua, Luo, Shaohong, Lin, Shen, Zhong, Lixian, Li, Meiyue, Xin, Rao, Huang, Pinfang, Xu, Xiongwei
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
DOI:
10.3727/096504019X15707883083132
Date:
March, 2020
File:
PDF, 663 KB
english, 2020
Conversion to is in progress
Conversion to is failed